ADAR1 Capital Management »

Biohaven shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Biohaven (BHVN) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Biohaven

Tip: Access up to 7 years of quarterly data

All positions including Biohaven held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biohaven by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $132k 2.6k 49.97
2024-03-31 $120k 2.2k 54.69

More positions owned by ADAR1 Capital Management

Cytokinetics Com New (CYTK)
Protagonist Therapeutics (PTGX)
Bridgebio Pharma (BBIO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Zura Bio Class A Ord Shs (ZURA)
Zai Lab Adr (ZLAB)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Aa Mission Acquisition Corp Ord Shs Cl A (AAM)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)

View all positions for ADAR1 Capital Management

Top funds holding Biohaven

Vanguard Group
BlackRock
Stifel Financial
Henderson Group
Suvretta Capital Management
Farallon Capital Management
T. Rowe Price Associates
State Street Corporation
RP Management
Bellevue Group
Citadel Advisors
FMR
Geode Capital Management
Point72 Asset Management
Perceptive Advisors

View all funds holding Biohaven